379 related articles for article (PubMed ID: 16866134)
1. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
Zheng W; Liu J; Meng DY; Hu XF; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
[TBL] [Abstract][Full Text] [Related]
2. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
[TBL] [Abstract][Full Text] [Related]
4. [L-arginine enhances Th1 immune response against Plasmodium yoelii 17XL infection in DBA/2 mice via activation of dendritic cells].
Pan YY; Liu J; Li Y; Yan J; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Aug; 29(4):247-51. PubMed ID: 21972595
[TBL] [Abstract][Full Text] [Related]
5. [Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii].
Yuan J; Xu B; Liu BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):47-51. PubMed ID: 15052774
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice.
Wang QH; Liu YJ; Liu J; Chen G; Zheng W; Wang JC; Cao YM
Exp Parasitol; 2009 Mar; 121(3):268-73. PubMed ID: 19109953
[TBL] [Abstract][Full Text] [Related]
7. Characterization of immune responses to single or mixed infections with P. yoelii 17XL and P. chabaudi AS in different strains of mice.
Chen G; Feng H; Liu J; Qi ZM; Wu Y; Guo SY; Li DM; Wang JC; Cao YM
Parasitol Int; 2010 Sep; 59(3):400-6. PubMed ID: 20609420
[TBL] [Abstract][Full Text] [Related]
8. Early treatment during a primary malaria infection modifies the development of cross immunity.
Legorreta-Herrera M; Ventura-Ayala ML; Licona-Chávez RN; Soto-Cruz I; Hernández-Clemente FF
Parasite Immunol; 2004 Jan; 26(1):7-17. PubMed ID: 15198641
[TBL] [Abstract][Full Text] [Related]
9. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
10. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium yoelii: cellular immune responses in splenectomized and normal mice.
Hauda KM; Sayles PC; Wassom DL
Exp Parasitol; 1993 Jun; 76(4):385-93. PubMed ID: 8513876
[TBL] [Abstract][Full Text] [Related]
12. [In vitro observation on effect of nitric oxide on exflagellation of Plasmodium yoelii].
Liu YJ; Wang JC; Feng H; Zhu XT; An CL; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):206-8, 212. PubMed ID: 18038779
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
Sayles PC; Wassom DL
J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
[TBL] [Abstract][Full Text] [Related]
15. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
[TBL] [Abstract][Full Text] [Related]
16. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
Rotman HL; Daly TM; Clynes R; Long CA
J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
[TBL] [Abstract][Full Text] [Related]
17. Distinct host-related dendritic cell responses during the early stage of Plasmodium yoelii infection in susceptible and resistant mice.
Zheng W; Wang QH; Liu YJ; Liu J; Feng H; Wu JJ; Cao YM
Parasite Immunol; 2010 May; 32(5):324-34. PubMed ID: 20500661
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium yoelii: distinct CD4(+)CD25(+) regulatory T cell responses during the early stages of infection in susceptible and resistant mice.
Wu Y; Wang QH; Zheng L; Feng H; Liu J; Ma SH; Cao YM
Exp Parasitol; 2007 Mar; 115(3):301-4. PubMed ID: 17084842
[TBL] [Abstract][Full Text] [Related]
19. Passive immunization against murine malaria with an IgG3 monoclonal antibody.
Majarian WR; Daly TM; Weidanz WP; Long CA
J Immunol; 1984 Jun; 132(6):3131-7. PubMed ID: 6725950
[TBL] [Abstract][Full Text] [Related]
20. Co-infection: the outcome of Plasmodium infection differs according to the time of pre-existing helminth infection.
Salazar-Castañón VH; Juárez-Avelar I; Legorreta-Herrera M; Govezensky T; Rodriguez-Sosa M
Parasitol Res; 2018 Sep; 117(9):2767-2784. PubMed ID: 29938323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
